Clearmind Medicine Inc. (CMND)
(Delayed Data from NSDQ)
$0.99 USD
-0.03 (-3.24%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.98 -0.01 (-0.71%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Clearmind Medicine Inc. has a market cap of $4.35M, which represents its share price of $1.02 multiplied by its outstanding shares number of 4.27M. As a small-cap company, CMND's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CMND 0.99 -0.03(-3.24%)
Will CMND be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CMND based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CMND
Psychedelic: Cybin receives European approval for EMBRACE study
Psychedelic: Cybin receives European approval for EMBRACE study
SciSparc-Clearmind collab leads to international patent application
Clearmind announces publication of international patent application under PCT
Clearmind Medicine Announces Publication of International Patent Application for Novel ...